Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | Celcuity Inc. CELC | Commodore Capital LP | 2,217,982 5.900% | -274,904 (-11.03%) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX | Commodore Capital LP | 3,350,000 4.960% | 3,350,000 (New Position) | Filing History |
| 2024-11-14 4:05 pm Unchanged | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | Nkarta, Inc. NKTX | Commodore Capital LP | 4,662,073 6.600% | 1,932,073 (+70.77%) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 10,497,990 9.300% | 4,325,904 (+70.09%) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | Spyre Therapeutics, Inc. SYRE | Commodore Capital LP | 1,988,084 3.900% | 54,000 (+2.79%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | Adicet Bio, Inc. ACET | Commodore Capital LP | 0 0.000% | -4,250,000 (Position Closed) | Filing History |
| 2024-10-25 4:05 pm Purchase | 2024-10-18 | 13G | Bright Minds Biosciences Inc. DRUG | Commodore Capital LP | 400,000 9.000% | 400,000 (New Position) | Filing History |
| 2024-10-17 4:05 pm Purchase | 2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT | Commodore Capital LP | 6,807,507 9.990% | 6,807,507 (New Position) | Filing History |
| 2024-06-21 4:05 pm Purchase | 2024-06-13 | 13G | Perceptive Capital Solutions Corp Class A Ordinary Shares PCSC | Commodore Capital LP | 750,000 7.000% | 750,000 (New Position) | Filing History |
| 2024-04-19 4:05 pm Purchase | 2024-04-11 | 13G | Perspective Therapeutics, Inc. CATX | Commodore Capital LP | 3,890,667 6.600% | 3,890,667 (New Position) | Filing History |
| 2024-03-21 4:05 pm Purchase | 2024-03-11 | 13G | Mind Medicine (MindMed) Inc. MNMD | Commodore Capital LP | 5,833,333 8.300% | 5,833,333 (New Position) | Filing History |
| 2024-02-14 4:10 pm Purchase | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | Commodore Capital LP | 5,450,000 12.300% | 448,217 (+8.96%) | Filing History |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | Immunic, Inc. IMUX | Commodore Capital LP | 0 0.000% | -2,873,563 (Position Closed) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Commodore Capital LP | 1,000,000 9.900% | 384,186 (+62.39%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 6,172,086 7.100% | 1,246,086 (+25.30%) | Filing History |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | Commodore Capital LP | 0 0.000% | -5,738,500 (Position Closed) | Filing History |
| 2024-02-14 4:05 pm Unchanged | 2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Commodore Capital LP | 1,900,000 4.400% | 441,633 (+30.28%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | Celcuity Inc. CELC | Commodore Capital LP | 2,492,886 9.900% | 235,474 (+10.43%) | Filing History |